These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26510017)

  • 1. Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
    Welch HG; Gorski DH; Albertsen PC
    N Engl J Med; 2015 Oct; 373(18):1685-7. PubMed ID: 26510017
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Metastatic Breast and Prostate Cancer.
    Fouad TM
    N Engl J Med; 2016 Feb; 374(6):595. PubMed ID: 26863371
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in Metastatic Breast and Prostate Cancer.
    Eby PR
    N Engl J Med; 2016 Feb; 374(6):595. PubMed ID: 26863370
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in Metastatic Breast and Prostate Cancer.
    Gaylis FD; Choi J; Kader AK
    N Engl J Med; 2016 Feb; 374(6):594-5. PubMed ID: 26863369
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in Metastatic Breast and Prostate Cancer.
    Welch HG; Gorski DH; Albertsen PC
    N Engl J Med; 2016 Feb; 374(6):596. PubMed ID: 26863368
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer trends in the United States--a view from Europe.
    Quinn MJ
    J Natl Cancer Inst; 2003 Sep; 95(17):1258-61. PubMed ID: 12953072
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer.
    Nyame YA; Gulati R; Tsodikov A; Gore JL; Etzioni R
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis.
    Abdollah F; Sun M; Sammon JD; Choueiri TK; Menon M; Weissman JS; Trinh QD
    JAMA Oncol; 2016 Apr; 2(4):543-5. PubMed ID: 26794060
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations.
    Barry MJ; Nelson JB
    J Urol; 2015 Dec; 194(6):1534-6. PubMed ID: 26384450
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced breast cancer in young women.
    Peres J
    J Natl Cancer Inst; 2013 Sep; 105(17):1257-8. PubMed ID: 23956454
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening and detection of breast cancer and prostate cancer.
    Saloustros E; Mavroudis D
    JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic prostate cancer incidence in Australia after amendment to prostate-specific antigen screening guidelines.
    Smith S; Wolanski P
    ANZ J Surg; 2018; 88(7-8):E589-E593. PubMed ID: 29194902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.
    Scosyrev E; Wu G; Mohile S; Messing EM
    Cancer; 2012 Dec; 118(23):5768-76. PubMed ID: 22847578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 17. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
    Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
    Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII.
    Marugame T; Katanoda K
    Jpn J Clin Oncol; 2006 Jun; 36(6):399-400. PubMed ID: 16818481
    [No Abstract]   [Full Text] [Related]  

  • 19. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.
    Wu JN; Fish KM; Evans CP; Devere White RW; Dall'Era MA
    Cancer; 2014 Mar; 120(6):818-23. PubMed ID: 24258693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?
    Downer MK; Stampfer MJ; Cooperberg MR
    JAMA Oncol; 2017 Dec; 3(12):1623-1624. PubMed ID: 28494051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.